Skip to main content

TIANYIN PHARMACEUTICAL CO., INC. — key financial figures for fiscal year 2014 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2014)
$46.6M
Net Income/Loss (FY2014)
-$808.1K
Total Assets (FY2014)
$106.9M
Total Equity (FY2014)
$97.7M
Cash Flows from Operating Activities (FY2014)
$2.5M

Source: TIANYIN PHARMACEUTICAL CO., INC. 10-K filing (FY2014). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

Discover Hub-Equity